Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > UQ's needle free vaccine delivery research recognised

Professor Kendall
Professor Kendall

Abstract:
University of Queensland researcher Professor Mark Kendall has been awarded the 2008 Amgen Medical Research Award for his excellence in translational medical research studies.

UQ's needle free vaccine delivery research recognised

Australia | Posted on June 6th, 2008

This national award is made annually by the Australian Society for Medical Research as part of Medical Research Week.

Professor Kendall leads a research team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) developing needle-free delivery of vaccines targeting the skin.

"I am delighted and honoured with the award, it offers me great encouragement at this stage of my career," Professor Kendall said.

"Our research is focused on practical needle-free devices accurately targeting key skin cells, with the goal of clinical application of better vaccines in both the developed and developing world.

"To help optimise our delivery devices, we are performing fundamental research into the mechanical and biological properties of the skin, together with vaccine delivery studies in key disease areas."

Professor Kendall joined UQ in 2006 as a joint appointment by AIBN, the Diamantina Institute for Cancer, Immunology and Metabolic Medicine and the Faculty of Health Sciences. Prior to this he was the Associate Director of the PowderJect Centre for Gene and Drug Delivery at Oxford University, UK.

In congratulating Professor Kendall, AIBN Director Professor Peter Gray said his work typified the research excellence to be found at the AIBN.

"Mark's work is multidisciplinary in nature, combining vaccine science, bioengineering together with biomaterials and microfabrication, and it typifies AIBN's dynamic research environment and industry focus," Professor Gray said.

Director of the Diamantina Institute Professor Ian Frazer said that Professor Kendall's work was an important collaboration between the Institutes.

"This collaborative project offers great hope in reducing the estimated 14 million deaths caused each year by infectious diseases and, due to its robustness and efficiency, could be of particular benefit in developing countries," Professor Frazer said.

The AIBN is a multi-disciplinary research institute based at UQ, which brings together the skills of world-class researchers in the areas of bioengineering and nanotechnology to produce positive health and environmental outcomes such as biomedical delivery; bio-devices; tissue regeneration; and cell therapies.

####

For more information, please click here

Contacts:
Professor Mark Kendall
0431 162 391
or
Russell Griggs
07 3346 3989

Copyright © University of Queensland

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

A new technique to make drugs more soluble August 28th, 2015

Nanocatalysts improve processes for the petrochemical industry August 28th, 2015

Nanomedicine

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

A new technique to make drugs more soluble August 28th, 2015

These microscopic fish are 3-D-printed to do more than swim: Researchers demonstrate a novel method to build microscopic robots with complex shapes and functionalities August 26th, 2015

Announcements

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

A new technique to make drugs more soluble August 28th, 2015

Nanocatalysts improve processes for the petrochemical industry August 28th, 2015

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

50 Years of Scanning Electron Microscopy from ZEISS: ZEISS celebrates the birth of the first commercial scanning electron microscope in 1965 August 26th, 2015

How UEA research could help build computers from DNA August 19th, 2015

'Quantum dot' technology may help light the future August 19th, 2015

Exercise-induced hormone irisin is not a 'myth' August 14th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic